[
  {
    "title": "ARVINAS, INC. AND SUBSIDIARIES",
    "subtitle": "Consolidated Balance Sheets (Unaudited)",
    "markdown": "| | December 31, 2023 | December 31, 2022 |\n| --- | --- | --- |\n| **Assets** | | |\n| **Current assets:** | | |\n| Cash and cash equivalents | $ 311.7 | $ 81.3 |\n| Restricted cash | 5.5 | 5.5 |\n| Marketable securities | 949.3 | 1,124.0 |\n| Accounts receivable | \u2014 | 1.0 |\n| Other receivables | 7.2 | 7.0 |\n| Prepaid expenses and other current assets | 6.5 | 21.4 |\n| Total current assets | 1,280.2 | 1,240.2 |\n| Property, equipment and leasehold improvements, net | 11.5 | 13.4 |\n| Operating lease right of use assets | 2.5 | 4.4 |\n| Collaboration contract asset and other assets | 10.4 | 10.8 |\n| **Total assets** | $ 1,304.6 | $ 1,268.8 |\n| **Liabilities and stockholders' equity** | | |\n| **Current liabilities:** | | |\n| Accounts payable and accrued liabilities | $ 92.2 | $ 74.7 |\n| Deferred revenue | 163.0 | 218.6 |\n| Current portion of operating lease liability | 1.9 | 1.8 |\n| Total current liabilities | 257.1 | 295.1 |\n| Deferred revenue | 386.2 | 405.1 |\n| Long term debt | 0.8 | 1.0 |\n| Operating lease liability | 0.5 | 2.7 |\n| **Total liabilities** | 644.6 | 703.9 |\n| **Stockholders' equity:** | | |\n| Preferred stock, $0.001 par value, zero shares issued and outstanding as of December 31, 2023 and 2022, respectively | \u2014 | \u2014 |\n| Common stock, $0.001 par value, 68.0 and 53.2 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 0.1 | 0.1 |\n| Accumulated deficit | (1,332.7) | (965.4) |\n| Additional paid-in capital | 1,995.7 | 1,549.4 |\n| Accumulated other comprehensive loss | (3.1) | (19.2) |\n| **Total stockholders' equity** | 660.0 | 564.9 |\n| **Total liabilities and stockholders' equity** | $ 1,304.6 | $ 1,268.8 |",
    "footnotes": [],
    "units": "(dollars and shares in millions, except per share amounts)",
    "page": 11,
    "bbox": [
      23.5,
      101.4,
      568.6,
      655.6
    ],
    "som_region": [
      0.03839231004901961,
      0.17228475243154198,
      0.9291288089128881,
      0.871993170844184
    ],
    "flavor": "stream",
    "source": "experiments/que259/inputs/102174103.pdf",
    "camelot_accuracy": 97.72,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "ARVINAS, INC. AND SUBSIDIARIES",
    "subtitle": "Consolidated Statements of Operations (Unaudited)",
    "markdown": "| | Three Months Ended December 31, 2023 | Three Months Ended December 31, 2022 | Year Ended December 31, 2023 | Year Ended December 31, 2022 |\n| --- | --- | --- | --- | --- |\n| Revenue | $ (43.1) | $ 38.0 | $ 78.5 | $ 131.4 |\n| Operating expenses: | | | | |\n| Research and development | 95.2 | 98.3 | 379.7 | 315.0 |\n| General and administrative | 27.0 | 15.1 | 100.3 | 79.6 |\n| Total operating expenses | 122.2 | 113.4 | 480.0 | 394.6 |\n| Loss from operations | (165.3) | (75.4) | (401.5) | (263.2) |\n| Interest and other income | 12.1 | 6.3 | 37.6 | 12.2 |\n| Net loss before income taxes and loss from equity method investment | (153.2) | (69.1) | (363.9) | (251.0) |\n| Income tax expense | (1.6) | (10.8) | (0.9) | (20.9) |\n| Loss from equity method investment | | (3.0) | (2.5) | (10.6) |\n| Net loss | $ (154.8) | $ (82.9) | $ (367.3) | $ (282.5) |\n| Net loss per common share - basic and diluted | $ (2.53) | $ (1.56) | $ (6.62) | $ (5.31) |\n| Weighted average common shares outstanding - basic and diluted | 61.1 | 53.2 | 55.5 | 53.2 |",
    "footnotes": [],
    "units": "(dollars and shares in millions, except per share amounts)",
    "page": 12,
    "bbox": [
      23.5,
      338.4,
      588.0,
      655.6
    ],
    "som_region": [
      0.03839231004901961,
      0.17228475243154198,
      0.9607029335171569,
      0.5727507851340554
    ],
    "flavor": "stream",
    "source": "experiments/que259/inputs/102174103.pdf",
    "camelot_accuracy": 96.43,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  }
]